Investigation of a novel DNase of Streptococcus suis serotype 2

被引:43
作者
Fontaine, MC [1 ]
Perez-Casal, J [1 ]
Willson, PJ [1 ]
机构
[1] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK S7N 5E3, Canada
关键词
D O I
10.1128/IAI.72.2.774-781.2004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A secreted nuclease, SsnA, was identified in the virulent Streptococcus suis isolate SX332 and subsequently in each of the type strains of capsular serotypes 1 through 9. Screening of 258 porcine clinical isolates from surface (nasal mucosa or palatine tonsil) or internal (Joint, brain or other internal organ) locations revealed a significant relationship (P < 0.001) between expression of nuclease and isolation from an internal site. A 3,126-bp gene, ssnA, was identified from a phenotypically nuclease-negative pGh9:ISS1 insertion mutant, and analysis of the predicted SsnA sequence revealed a 35-amino-acid (aa) secretion signal sequence, a 22-aa DNA-binding domain, and a typical gram-positive cell wall sorting motif. A requirement of Ca2+ and Mg2+ for SsnA activity was determined, and the substrate specificity was found to be for single- and double-stranded linear DNA. Reverse transcription-PCR experiments revealed that ssnA is expressed throughout all stages of S. suis growth, and Western blots with porcine anti-S. suis immune sera against a recombinant, truncated SsnA derivative (rSsnA(Delta)) confirmed that SsnA is expressed in vivo. Furthermore, anti-rSsnA(Delta) antibodies were sufficient to neutralize SsnA activity. Analyses of subcellular fractions of SX332 and derived mutants, on DNA-containing polyacrylamide gels and by Western blotting, suggest that SsnA is cell wall located.
引用
收藏
页码:774 / 781
页数:8
相关论文
共 47 条
  • [1] Generation and characterization of a defined mutant of Streptococcus suis lacking suilysin
    Allen, AG
    Bolitho, S
    Lindsay, H
    Khan, S
    Bryant, C
    Norton, P
    Ward, P
    Leigh, J
    Morgan, J
    Riches, H
    Eastty, S
    Maskell, D
    [J]. INFECTION AND IMMUNITY, 2001, 69 (04) : 2732 - 2735
  • [2] Alouf J.E., 1991, SOURCEBOOK BACTERIAL, P147
  • [3] AYOUB EM, 1962, PEDIATRICS, V29, P527
  • [4] Role of Mycoplasma penetrans endonuclease P40 as a potential pathogenic determinant
    Bendjennat, M
    Blanchard, A
    Loutfi, M
    Montagnier, L
    Bahraoui, E
    [J]. INFECTION AND IMMUNITY, 1999, 67 (09) : 4456 - 4462
  • [5] Berthelot-Hérault F, 2000, VET RES, V31, P473, DOI 10.1051/vetres:2000133
  • [7] HIGH-EFFICIENCY GENE INACTIVATION AND REPLACEMENT SYSTEM FOR GRAM-POSITIVE BACTERIA
    BISWAS, I
    GRUSS, A
    EHRLICH, SD
    MAGUIN, E
    [J]. JOURNAL OF BACTERIOLOGY, 1993, 175 (11) : 3628 - 3635
  • [8] Streptococcus suis serotype 2 mutants deficient in capsular expression
    Charland, N
    Harel, J
    Kobisch, M
    Lacasse, S
    Gottschalk, M
    [J]. MICROBIOLOGY-SGM, 1998, 144 : 325 - 332
  • [9] STREPTOCOCCUS-SUIS MENINGITIS
    CHAU, PY
    HUANG, CY
    KAY, R
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1983, 1 (09) : 414 - 417
  • [10] DETECTION OF STAPHYLOCOCCAL NUCLEASE ELABORATED DURING LETHAL INFECTIONS IN MICE
    CHESBRO, W
    WALKER, R
    [J]. INFECTION AND IMMUNITY, 1972, 6 (06) : 1028 - &